These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 9403642

  • 21. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL, Van Aerde JE, Gross S, Stolz SI, Harris CL, Hansen JW.
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [Abstract] [Full Text] [Related]

  • 22. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G.
    N Engl J Med; 1994 Apr 28; 330(17):1173-8. PubMed ID: 8139627
    [Abstract] [Full Text] [Related]

  • 23. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.
    Bader D, Blondheim O, Jonas R, Admoni O, Abend-Winger M, Reich D, Lanir A, Tamir A, Eldar I, Attias D.
    Acta Paediatr; 1996 Apr 28; 85(4):496-501. PubMed ID: 8740313
    [Abstract] [Full Text] [Related]

  • 24. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.
    Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguía M, Digregorio J, Vecchiarelli C, Valverde R, García C, Subotovsky P, Solana C, Gorenstein A.
    Pediatrics; 2000 May 28; 105(5):1066-72. PubMed ID: 10790464
    [Abstract] [Full Text] [Related]

  • 25. Effect of recombinant human erythropoietin on transfusion needs in preterm infants.
    Yeo CL, Choo S, Ho LY.
    J Paediatr Child Health; 2001 Aug 28; 37(4):352-8. PubMed ID: 11532054
    [Abstract] [Full Text] [Related]

  • 26. Erythropoietin and prematurity--where do we stand?
    Carbonell-Estrany X, Figueras-Aloy J, Alvarez E.
    J Perinat Med; 2005 Aug 28; 33(4):277-86. PubMed ID: 16207112
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.
    Ohls RK, Kamath-Rayne BD, Christensen RD, Wiedmeier SE, Rosenberg A, Fuller J, Lacy CB, Roohi M, Lambert DK, Burnett JJ, Pruckler B, Peceny H, Cannon DC, Lowe JR.
    Pediatrics; 2014 Jun 28; 133(6):1023-30. PubMed ID: 24819566
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants.
    Birenbaum HJ, Pane MA, Helou SM, Starr KP.
    South Med J; 2006 Oct 28; 99(10):1059-62. PubMed ID: 17100024
    [Abstract] [Full Text] [Related]

  • 31. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.
    Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F.
    J Pediatr; 1992 Jul 28; 121(1):98-102. PubMed ID: 1625101
    [Abstract] [Full Text] [Related]

  • 32. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J, Haddad J, Donato L, Astruc D, Matis J.
    Pediatrics; 1993 Oct 28; 92(4):519-23. PubMed ID: 8414820
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of erythropoietin in premature infants.
    Amin AA, Alzahrani DM.
    Saudi Med J; 2002 Mar 28; 23(3):287-90. PubMed ID: 11938417
    [Abstract] [Full Text] [Related]

  • 34. Recombinant erythropoietin and blood transfusion in selected preterm infants.
    Meyer MP, Sharma E, Carsons M.
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan 28; 88(1):F41-5. PubMed ID: 12496225
    [Abstract] [Full Text] [Related]

  • 35. Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.
    Bierer R, Roohi M, Peceny C, Ohls RK.
    J Pediatr Surg; 2009 Aug 28; 44(8):1540-5. PubMed ID: 19635302
    [Abstract] [Full Text] [Related]

  • 36. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.
    Tempera A, Stival E, Piastra M, De Luca D, Ottaviano C, Tramontozzi P, Marconi M, Cafforio C, Marcozzi P, Rossi N, Buffone E.
    J Matern Fetal Neonatal Med; 2011 Aug 28; 24(8):1060-4. PubMed ID: 21250913
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM, Mentzer WC, Abels RI, Wertz M, Thayer-Moriyama J, Li WY, Thompson D, Decelle S, Phibbs RH.
    J Pediatr; 1992 Apr 28; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [Abstract] [Full Text] [Related]

  • 38. Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates.
    Juul SE.
    J Pediatr; 2003 Sep 28; 143(3):321-6. PubMed ID: 14517513
    [Abstract] [Full Text] [Related]

  • 39. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis.
    Tchernia G, Delhommeau F, Perrotta S, Cynober T, Bader-Meunier B, Nobili B, Rohrlich P, Salomon JL, Sagot-Bevenot S, del Giudice EM, Delaunay J, DeMattia D, Schischmanoff PO, Mohandas N, Iolascon A, ESPHI working group on hemolytic anemias.
    Hematol J; 2000 Sep 28; 1(3):146-52. PubMed ID: 11920183
    [Abstract] [Full Text] [Related]

  • 40. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia.
    Ohls RK, Hunter DD, Christensen RD.
    J Pediatr; 1993 Dec 28; 123(6):996-1000. PubMed ID: 8229537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.